Could a blood concentrate make cochlear implants work better?

NCT ID NCT05215197

Recruiting now Disease control Sponsor: Pamukkale University Source: ClinicalTrials.gov ↗

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This trial investigates whether applying platelet-rich fibrin inside the ear during cochlear implant surgery can reduce scarring and improve implant performance. Scarring often limits how well the implant works and increases its power use. The study includes people with sensorineural hearing loss who are receiving a specific type of cochlear implant. Researchers will measure electrode impedance and thresholds over six months to see if the treatment helps.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: platelet-rich fibrin applied inside the cochlea during cochlear implant surgery
What this could lead to: If it works, this could improve hearing outcomes and reduce power needs for cochlear implant users.
What could go wrong: This is a very small early study with only 10 participants, so results may not apply broadly. The procedure also carries surgical risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEARING LOSS, SENSORINEURAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hearing Loss, Sensorineural sensorineural hearing loss disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEARING LOSS, SENSORINEURAL

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Pamukkale University
RECRUITING

Denizli, 20070, Turkey (Türkiye)

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.